Differential effects of threat types on attentional processes: a comparison of snakes and blood-injury-injection stimuli.

Front Psychiatry

Institute of Psychology, Faculty of Humanities and Social Sciences, University of Pécs, Pécs, Hungary.

Published: December 2024

Introduction: Previous research on the visual processing of threats has largely overlooked the Q8 distinct effects of various types of threats, despite evidence suggesting unique brain activation patterns for specific fears. Our study examines the differential effects of threat types on attentional processes, focusing on snakes and blood-injury-injection (BII) stimuli. We sought to test whether these two types of threat stimuli, as taskirrelevant distractors, would lead to similar effects in a visual search task.

Methods: Participants were exposed to emotionally charged stimuli of varying arousal (medium and high) and neutral pictures of low arousal as task-irrelevant distractors while performing a primary visual search task.

Results: We found that BII-related distractor pictures interfered with attention to the primary task, resulting in slower reaction times compared to snake pictures. In addition, BII-related medium arousal stimuli decreased, but high arousal facilitated both orienting and executive attentional performance. Exploratory analysis of personality traits revealed differential effects of trait anxiety and disgust sensitivity, highlighting the unique mechanisms underlying fear responses. In addition, participants who used adaptive emotion regulation strategies showed better performance in overcoming the interference of threat stimuli on attention.

Discussion: These findings underscore the importance of considering individual differences and emotion regulation strategies in fear research and provide insight into the complex interplay between threat perception and attentional processes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704487PMC
http://dx.doi.org/10.3389/fpsyt.2024.1498709DOI Listing

Publication Analysis

Top Keywords

differential effects
12
attentional processes
12
effects threat
8
threat types
8
types attentional
8
snakes blood-injury-injection
8
threat stimuli
8
visual search
8
emotion regulation
8
regulation strategies
8

Similar Publications

Drug Development.

Alzheimers Dement

December 2024

Aptah Bio Inc., San Carlos, CA, USA.

Background: Alzheimer's disease (AD) is the most common cause of dementia worldwide. It is characterized by dysfunction in the U1 small nuclear ribonucleoproteins (snRNPs) complex, which may precede TAU aggregation, enhancing premature polyadenylation, spliceosome dysfunction, and causing cell cycle reentry and death. Thus, we evaluated the effects of a synthetic single-stranded cDNA, called APT20TTMG, in induced pluripotent stem cells (iPSC) derived neurons from healthy and AD donors and in the Senescence Accelerated Mouse-Prone 8 (SAMP8) model.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

AC Immune SA, Lausanne, Switzerland.

Background: The key advantage of active immunization is the induction of sustained, polyclonal antibody responses that are readily boosted by occasional immunizations. Recent clinical trial outcomes for monoclonal antibodies lecanemab and donanemab, establish the relevance of targeting pathological Abeta for clearing amyloid plaques in Alzheimer's disease. ACI-24.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Retromer Therapeutics, New York, NY, USA.

Background: Convergent evidence indicates that deficits in the endosomal recycling pathway underlies pathogenesis of Alzheimer's disease (AD). SORL1 encodes the retromer-associated receptor SORLA that plays an essential role in recycling of AD-associated cargos such as the amyloid precursor protein and the glutamatergic AMPA receptor. Importantly, loss of function pathogenic SORL1 variants are associated with AD.

View Article and Find Full Text PDF

Background: Alzheimer's disease (AD) is the most prevalent cause of dementia accounting for an estimated 60% to 80% of cases. Despite advances in the research field, developing truly effective therapies for AD symptoms remains a major challenge. Sweet almond contain nutrients that have the potential of combating age-related brain dysfunction, by improving learning, memory and neurocognitive performance.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Beckman Research Institute of City of Hope, Duarte, CA, USA.

Background: Brain organoid models were generated from healthy control or Alzheimer's disease patient iPSCs to facilitate our understanding of AD pathogenesis.

Method: ApoE3 and ApoE4 iPSCs were developed into brain organoids using our recently developed brain organoid platform that allows prolonged culture of brain organoids. Human iPSCs were also differentiated into microglia, which were then co-cultured with brain organoids.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!